Quick Answer
Organogenesis Holdings Inc. reported Diluted EPS of $0.15 per share for fiscal year 2025.
Organogenesis Holdings Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.15 | +1600.0% |
| 2024 | -$0.01 | -125.0% |
| 2023 | $0.04 | -66.7% |
| 2022 | $0.12 | -82.9% |
| 2021 | $0.70 | +366.7% |
| 2020 | $0.15 | +135.7% |
| 2019 | -$0.42 | +55.3% |
| 2018 | -$0.94 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.11 | +22.2% | +210.0% |
| June 30, 2025 | -$0.10 | +23.1% | +41.2% |
| March 31, 2025 | -$0.17 | -750.0% | -288.9% |
| September 30, 2024 | $0.09 | +350.0% | +169.2% |
| June 30, 2024 | -$0.13 | -425.0% | -550.0% |
| March 31, 2024 | -$0.02 | +0.0% | -200.0% |
| September 30, 2023 | $0.02 | — | -50.0% |
| June 30, 2023 | $0.04 | -42.9% | +300.0% |
- Organogenesis Holdings Inc. showed an increase of +1600.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, Organogenesis Holdings Inc.’s diluted eps has grown by 116.0% (from $0.94 per share (loss) to $0.15 per share).
- The most recent figure is from Organogenesis Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: